Andrea Cortese's research works | University of Pavia, Pavia …
Andrea Cortese's 176 research works with 3,892 citations and 14,180 reads, including: Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease
Effect of bead size and doxorubicin loading on tumor cellular …
Embolic agents used in transarterial embolization for intermediate stage hepatocellular carcinoma reduce blood flow into tumors and can deliver anticancer drugs. Tumor blood supply can be …
RFC1 CANVAS / Spectrum Disorder - GeneReviews® - NCBI Bookshelf
Nov 25, 2020 · Andrea Cortese's work focuses on genetic discovery, functional modeling, and treatment of neuromuscular diseases and other hereditary neurodegenerative conditions. A …
Andrea CORTES | Ms | University of Texas MD Anderson Cancer …
Andrea CORTES | Cited by 342 | of University of Texas MD Anderson Cancer Center, Texas (MD Anderson) | Read 44 publications | Contact Andrea CORTES
Bioresorbable Mesenchymal Stem Cell-Loaded Electrospun
Jul 3, 2023 · Bioresorbable perivascular scaffolds loaded with antiproliferative agents have been shown to enhance arteriovenous fistula (AVF) maturation by inhibiting neointimal hyperplasia …
A CADM3 variant causes Charcot-Marie-Tooth disease with …
May 7, 2021 · We have identified-by whole exome sequencing-three unrelated families, including one de novo patient, with axonal Charcot-Marie-Tooth disease (CMT2) sharing the same …
truncating variants on RFC1 expression, we tested the level of RFC1 transcript and protein on patients’ derived cell lines.
Andrea Cortese Hassett - ResearchGate
Andrea CORTESE HASSETT | Cited by 1,300 | of University of Pittsburgh, PA (Pitt) | Read 51 publications | Contact Andrea CORTESE HASSETT
Andrea Cortese (0000-0002-2208-5311) - ORCID
ORCID record for Andrea Cortese. ORCID provides an identifier for individuals to use with their name as they engage in research, scholarship, and innovation activities.
SORD Research - Charcot–Marie–Tooth Association
The initial discovery was made by Andrea Cortese, MD, and Adriana Rebelo, PhD, who worked with a large group of CMT2 families convened by the Inherited Neuropathy Consortium, with …
- Some results have been removed